CoChat

Update: Hypogonadotropic Hypogonadism in Type 2 Diabetes and Obesity

Open access
Dandona, Paresh, Dhindsa, Sandeep · 2011 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.

Abstract

Studies over the last few years have clearly established that at least 25% of men with type 2 diabetes have subnormal free testosterone concentrations in association with inappropriately low LH and FSH concentrations. Another 4% have subnormal testosterone concentrations with elevated LH and FSH concentrations. The Endocrine Society, therefore, now recommends the measurement of testosterone in patients with type 2 diabetes on a routine basis. The subnormal testosterone concentrations are not related to glycosylated hemoglobin or duration of diabetes, but are associated with obesity, very high C-reactive protein concentrations, and mild anemia. In addition, subnormal testosterone concentrations in these men are associated with a two to three times elevated risk of cardiovascular events and death in two early studies. Short-term studies of testosterone therapy in hypogonadal men with type 2 diabetes have demonstrated an increase in insulin sensitivity and a decrease in waist circumference. However, the data on the effect of testosterone replacement on glycemic control and cardiovascular risk factors such as cholesterol and C-reactive protein concentrations are inconsistent. As far as sexual function is concerned, testosterone treatment increases libido but does not improve erectile dysfunction and thus, phosphodiesterase inhibitors may be required. Trials of a longer duration are clearly required to definitively establish the benefits and risks of testosterone replacement in patients with type 2 diabetes and low testosterone.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2010-2724

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 76 references

Cited by

See all 313

Metadata

Authors
Dandona, P., & Dhindsa, S.
Affiliations
Kaleida Health (US)
Corresponding author
Dandona, Paresh
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2011-09-01
Volume
96
Issue
9
Pages
2643-2651
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2111728603
Cited by
313
References
75
Citations by year
2026: 15 · 2025: 15 · 2024: 16 · 2023: 22 · 2022: 18 · 2021: 24 · 2020: 14 · 2019: 19 · 2018: 29 · 2017: 19 · 2016: 16 · 2015: 27 · 2014: 24 · 2013: 36 · 2012: 17
FWCI
3.53
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01dk069805-04)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK069805, R01DK075877)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
hypogonadotropic hypogonadism, type 2 diabetes, obesity, androgen deficiency, free testosterone, luteinizing hormone, follicle-stimulating hormone, testosterone replacement therapy, insulin sensitivity, cardiovascular risk, C-reactive protein, anemia, sexual function, erectile dysfunction, phosphodiesterase inhibitors, waist circumference
MeSH terms
Diabetes Mellitus, Type 2, Humans, Hypogonadism, Male, Obesity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Update: Hypogonadotropic Hypogonadism in Type 2 Diabetes and Obesity. https://app.cochat.ai/papers/10.1210/jc.2010-2724
The paper
Dandona, P., & Dhindsa, S. (2011). Update: Hypogonadotropic Hypogonadism in Type 2 Diabetes and Obesity. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2010-2724

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.